Determining the difference in medication compliance between the general patient population and patients receiving antihypertensive therapy: A case study

Archives of Pharmacal Research

Volumn 34, Issue 7, 2011, Pages 1143-1152

  Culig, Josip ^a,b   Leppée, Marcel ^a   Boskovic, Jelena ^c   Eric, Mirela ^d  

^a UNIVERSITY OF ZAGREB   (Croatia)

^b JOSIP JURAJ STROSSMAYER UNIVERSITY OF OSIJEK   (Croatia)

^c UNIVERSITY OF ZAGREB   (Croatia)

^d UNIVERSITY OF NOVI SAD   (Serbia)

Author keywords

Age; Arterial hypertension; Compliance; Medications

Indexed keywords

ANTIHYPERTENSIVE AGENT;

ADULT; AGE; AGED; ANTIHYPERTENSIVE THERAPY; ARTICLE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DRUG EFFECT; FEMALE; GROUPS BY AGE; HEALTH SURVEY; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; PATIENT ATTITUDE; PATIENT COMPLIANCE; PHYSICIAN; POPULATION RESEARCH; PRESCRIPTION;

ADULT; AGED; ANTIHYPERTENSIVE AGENTS; ATTITUDE TO HEALTH; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; HYPERTENSION; MALE; MEDICATION ADHERENCE; MIDDLE AGED; PATIENT COMPLIANCE; PHYSICIANS; QUESTIONNAIRES; TUNICA INTIMA;

EID: 80052335064     PISSN: 02536269     EISSN: 19763786     Source Type: Journal    
DOI: 10.1007/s12272-011-0712-0     Document Type: Article

References (29)

1. J. Benson N. Britten 2002 Patients' decisions about whether or not to take antihypertensive drugs: qualitative study BMJ 325 873 12386041 10.1136/bmj.325.7369.873
2. J. Benson N. Britten 2003 Patients' views about taking antihypertensive drugs: questionnaire study BMJ 326 1314 1315 12805171 10.1136/bmj.326.7402.1314
3. R. Collins R. Peto S. MacMahon P. Hebert N. H. Fiebach K. A. Eberlein J. Godwin N. Qizilbash J. O. Taylor C. H. Hennekens 1990 Blood pressure, stroke and coronary heart disease. Part II, Short-term reductions in blood pressure: overview of randomised drug trials in their epidemiological context Lancet 335 827 838 1969567 10.1016/0140-6736(90)90944-Z 1:STN:280:DyaK3c3gsFeruw%3D%3D (Pubitemid 20113741)
4. R. Collins S. MacMahon 1994 Blood pressure, antihypertensive drug treatment and the risks of stroke and of coronary heart disease Br. Med. Bull. 50 272 298 8205459 1:STN:280:DyaK2c3msFSksA%3D%3D (Pubitemid 24165020)
5. S. J. Coons S. L. Sheahan S. S. Martin J. Hendricks C. A. Robbins J. A. Johnson 1994 Predictors of medication noncompliance in a sample of older adults Clin. Ther. 16 110 117 8205597 1:STN:280:DyaK2c3msFagtw%3D%3D (Pubitemid 24186956)
6. F. V. Costa 1996 Compliance with antihypertensive treatment Clin. Exp. Hypertens. 18 463 472 8743035 10.3109/10641969609088977 1:STN:280: DyaK283osFOqsQ%3D%3D (Pubitemid 26147311)
7. J. J. Gascón M. Sánchez-Ortuño B. Llor D. Skidmore P. J. Saturno 2004 Why hypertensive patients do not comply with the treatment: results from a qualitative study Fam. Pract. 21 125 130 15020377 10.1093/fampra/cmh202 (Pubitemid 38489390)
8. Haynes, R. B., Determinants of compliance: the disease and the mechanics of treatment. In Haynes, R. B., Taylor, D. W., and Sackett, D. L. (Eds.). Compliance in Health Care. Johns Hopkins University Press, Baltimore, pp. 49-62, (1979).
9. R. B. Haynes E. Ackloo N. Sahota H. P. McDonald X. Yao 2008 Interventions for enhancing medication adherence Cochrane Database Syst. Rev. 16 CD000011
10. F. J. He G. A. MacGregor 2003 Cost of poor blood pressure control in the UK: 62,000 unnecessary deaths per year J. Hum. Hypertens. 17 455 457 12821951 10.1038/sj.jhh.1001581 1:STN:280:DC%2BD3s3psVensw%3D%3D (Pubitemid 36903331)
11. Hennekens, C. H., Clinical trials in cardiovascular disease: a companion to Braunwald's heart disease. W.B. Saunders, Philadelphia, pp. 79-94, (1999).
12. J. C. Hershey B. G. Morton J. B. Davis M. J. Reichgott 1980 Patient compliance with antihypertensive medication Am. J. Public Health 70 1081 1089 7416325 10.2105/AJPH.70.10.1081 1:STN:280:DyaL3M%2FhvFelsw%3D%3D (Pubitemid 10060044)
13. R. Horne J. Weinman M. Hankins 1999 The beliefs about medicines questionnaire: the development and evaluation of a new method for assessing the cognitive representation of medication Psychol. Health 14 1 24 10.1080/08870449908407311
14. W. B. Kannel 1996 Blood pressure as a cardiovascular risk factor: prevention and treatment JAMA 275 1571 1576 8622248 10.1001/jama.275.20.1571 1:STN:280:DyaK283htl2jsw%3D%3D (Pubitemid 26154243)
15. K. I. Kjellgren J. Ahlner R. Säljö 1995 Taking antihypertensive medication - controlling or co-operating with patients? Int. J. Cardiol. 47 257 268 7721502 10.1016/0167-5273(94)02203-U 1:STN:280:DyaK2M3jvVSmtA%3D%3D
16. C. M. Langman A. C. Lyons G. Y. H. Lip 2001 Perceptions and behaviour of hypertensive patients: a divine intervention or a case for Hippocrates? J. Hum. Hypertens. 15 751 754 11687917 10.1038/sj.jhh.1001277 1:STN:280: DC%2BD3MnjvFahsw%3D%3D (Pubitemid 33054196)
17. Medical Research Council Working Party. Medical Research Council trial of treatment of hypertension in older adults. 1992 Principal results BMJ 304 405 412 10.1136/bmj.304.6824.405
18. M. G. Myers 1999 Compliance in hypertension: why don't patients take their pills? CMAJ 160 64 65 9934346 1:STN:280:DyaK1M7jtlWjuw%3D%3D (Pubitemid 29054229)
19. Nunnally, J. C. and Bernstein, I. H., Psychometric theory. McGraw Hill, New York, pp. 264-265, (1994).
20. L. Osterberg T. Blaschke 2005 Adherence to medication N. Engl. J. Med. 353 487 497 16079372 10.1056/NEJMra050100 1:CAS:528:DC%2BD2MXntVCisL0%3D (Pubitemid 41127293)
21. Porter, R. S. and Kaplan, J. L. (Eds.). The Merck Manual Home Health Handbook. Merck Research Laboratories. Merck & Co., Inc, New Jersey, (2008).
22. C. S. Rand 1993 Measuring adherence with therapy for chronic diseases: implications for the treatment of heterozygous familial hypercholesterolemia Am. J. Cardiol. 72 68D 74D 8213501 10.1016/0002-9149(93)90014-4 1:STN:280:DyaK2c%2Fis1Oitg%3D%3D (Pubitemid 23286506)
23. S. Ross A. Walker M. J. MacLeod 2004 Patient compliance in hypertension: role of illness perceptions and treatment beliefs J. Hum. Hypertens. 18 607 613 15029218 10.1038/sj.jhh.1001721 1:STN:280:DC%2BD2cvhslSrtA%3D%3D (Pubitemid 39232344)
24. R. B. Singer 1992 Stroke in the elderly treated for systolic hypertension (SHEP) Part II-mortality J. Insur. Med. 24 28 31 10148474 1:STN:280: DyaK3sbgtl2iuw%3D%3D
25. S. Svensson K. I. Kjellgren J. Ahlner R. Säljö 2000 Reasons for adherence with antihypertensive medication Int. J. Cardiol. 76 157 163 11104870 10.1016/S0167-5273(00)00374-0 1:STN:280:DC%2BD3M7ktlymuw%3D%3D
26. G. Thrall G. Y. H. Lip D. Lane 2004 Compliance with pharmacological therapy in hypertension: can we do better, and how? J. Hum. Hypertens. 18 595 597 15029219 10.1038/sj.jhh.1001722 1:STN:280:DC%2BD2cvhslSrtQ%3D%3D (Pubitemid 39232343)
27. B. Vrijens R. Gross J. Urquhart 2005 The odds that clinically unrecognized poor or partial adherence confuses population pharmacokinetic/ pharmacodynamic analyses BCPT 96 225 227 1:CAS:528:DC%2BD2MXisFSlsr4%3D (Pubitemid 40387999)
28. M. A. Weingarten B. S. Cannon 1988 Age as a major factor affecting adherence to medication for hypertension in a general practice population Fam. Pract. 5 294 296 3068088 10.1093/fampra/5.4.294 1:STN:280:DyaL1M7ltlyhtw%3D%3D (Pubitemid 19031117)
29. World Health Organization. Adherence to long-term therapies-evidence for action. WHO, Switzerland, (2003).